Surabhi Gautam

Dr. Surabhi Gautam

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2019 in Restorative Neurology and Neuroscience
Verified
Journal Article
Closed access
PDF file
SGSurabhi Gautam
Surabhi Gautam
MTMadhuri Tolahunase
Madhuri Tolahunase
UKUma Kumar
Uma Kumar
RDRima Dada
Rima Dada
Background: Recovery of patients with rheumatoid arthritis (RA) depends on several physical and psychological factors, besides pharmacological treatment. Co-morbid depression adversely affects the outcome in RA. Usual medical therapies have a limited scope and fail to cure the psychological component of the disease. With advanced therapeutic options, achieving a state of remission has become the treatment goal, yoga based mind body intervention (MBI) may provide a holistic approach in its treatment dimension. Hence, MBIs are the need of hour as majority of diseases have a psychosomatic component. Objective: To explore the effect of Yoga based MBI on disease specific inflammatory markers and depression severity in active RA patients on routine disease modifying anti-rheumatic drugs (DMARDs) therapy. Methods: A total of 72 RA patients were randomized into 2 groups: yoga group (yoga with DMARDs) and control group (DMARDs only). Blood samples were collected pre and post intervention for primary outcome measurements of systemic biomarkers. Disease activity score 28, erythrocyte sedimentation rate (DAS28ESR) and health assessment questionnaire disability index (HAQ-DI) were used to assess disease activity and functional status respectively at pre and post intervention time-points. Secondary outcome, depression severity, was assessed by Beck Depression Inventory II scale (BDI-II) at 2 weekly intervals during 8 weeks of the study interventional plan. Results: After 8 weeks of yoga based MBI, there was significant decrease in the severity of RA as seen by reduction in levels of various systemic inflammatory markers as well as in DAS28ESR ( p-value <0.0001; effect size = 0.210) and HAQ-DI ( p-value 0.001; effect size = 0.159). Also, yoga group experienced a statistically significant time dependent step-wise decline in depression symptoms over the period of 8 weeks as compared to control group ( p-value <0.0001; effect size = 0.5). Regression analysis showed greater reduction in the scores of BDI-II with DAS28ESR (R2 = 0.426; p < 0.0001) and HAQ-DI (R2 = 0.236; p = 0.003) in yoga group. Conclusions: Yoga, a mind body intervention re-established immunological tolerance by aiding remission at molecular and cellular level along with significant reduction in depression. Thus in this severe autoimmune inflammatory arthritis with a major psychosomatic component, yoga can be used as a complementary/adjunct therapy.

28 May 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SGShivani Gupta
Shivani Gupta
SGSurabhi Gautam
Surabhi Gautam
UKUma Kumar
Uma Kumar
TATaruna Arora
Taruna Arora
RDRima Dada
Rima Dada
Pain is an unpleasant and upsetting experience. Persistent pain has an impact on an individual’s quality of life which causes stress and mood disorders. There are currently no pain-relieving techniques available that can eliminate pain and offer relief without causing any adverse effects. These factors draw attention to traditional treatments like yoga and meditation, which can reduce biological stress and hence increase immunity, as well as alleviate the psychological and emotional suffering produced by pain. Yoga reduces the stress response and the pain cascade via the downregulation of the hypothalamus-pituitary-adrenal (HPA) axis and vagal stimulation. Yoga is a cost-effective growing health practice that, unlike pharmaceuticals, has no side effects and can help patients stay in remission for longer periods of time with fewer relapses. Yoga not only reduces stress and depression severity but also improves functional status and reduces pain perception. This article highlights the impact of yoga on pain management and on a malfunctioning immune system, which leads to improved health, pain reduction, disease management, and improvement in overall quality of life.

5 September 2019 in Immunological Investigations
Verified
Journal Article
Open access
SGSurabhi Gautam
Surabhi Gautam
UKUma Kumar
Uma Kumar
MKManoj Kumar
Manoj Kumar
UMA KANGAUMA KANGA
UMA KANGA
RDRima Dada
Rima Dada
Background: Human leukocyte antigen (HLA)-G antigens are inducible non-classical major histocompatibility complex class Ib molecules which play an important role in the regulation of inflammatory processes and immunomodulation in autoimmune diseases. There are controversial reports on the impact of HLA-G gene polymorphisms on rheumatoid arthritis (RA). This study aimed at examining the impact of 14 base pair (bp) ins/del (rs66554220) and +3142G>C (rs1063320) polymorphisms and correlating these with soluble HLA-G (sHLA-G) levels to understand the susceptibility to RA in our sample cohort. Methods: Genomic DNA from 140 RA patients and 125 healthy controls was isolated using the salting out method. The genotyping of two polymorphisms of HLA-G (+3142G>C and 14 bp ins/del) was done by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) and PCR method, respectively. Levels of sHLA-G were estimated by ELISA and disease activity was calculated by disease activity score (DAS28-ESR). Results: The HLA-G +3142G>C polymorphism was found to be associated with a decreased risk of RA as attributed to recessive inheritance tested model results (OR = 0.4, 95%C.I. = 0.2–0.9, p = .0313*, GG + GC versus CC). Our finding did not support an association between HLA-G 14 bp ins/del variant and risk/protection of RA. The sHLA-G levels were significantly lower in +3142GG and +3142GC RA patients as compared to healthy controls. Conclusion: HLA-G +3142G>C gene polymorphism might decrease the risk of occurrence of RA in our sample cohort as +3142CC genotype is associated with increased sHLA-G levels. Abbreviations: HLA-G: human leukocyte antigen-G; RA: rheumatoid arthritis; MHC: major histocompatibility complex; UTR: untranslated region; URR: upstream regulatory region; SLE: systemic lupus erythematous; PCR-RFLP: polymerase chain reaction restriction fragment length polymorphism; sHLA-G: soluble HLA-G; bp: base pair; ACR/EULAR: American College of Rheumatology/European League against Rheumatism; RF: rheumatoid factor; Anti-CCP: anti-cyclic citrullinated peptide; DAS28-ESR: Disease Activity Score 28- Erythrocyte Sedimentation Rate; TJC: tender joint count; SJC: swollen joint count; ESR: erythrocyte sedimentation rate; PGA: patient global assessment; HTN: hypertension; DM: diabetes mellitus; TB: tuberculosis; IEC: Institute Ethics Committee; ELISA: enzyme linked immunosorbent assay; ROC: receiver operating characteristics; AUC: area under curve; SNP: single nucleotide polymorphism; MTX: methotrexate; DMARDs: disease modifying anti-rheumatic drugs; Treg: regulatory T cells; IL: interleukin Units: soluble HLA-G: Units/mL {U/mL}

1 December 2018 in Journal of the Anatomical Society of India
Verified
Journal Article
Closed access
SGSurabhi Gautam
Surabhi Gautam
BCBhavna Chawla
Bhavna Chawla
SBShilpa Bisht
Shilpa Bisht
MTMadhuri Tolahunase
Madhuri Tolahunase
RDRima Dada
Rima Dada

1 January 2015 in Clinical Epidemiology and Global Health
Verified
Journal Article
Closed access
SGSurabhi Gautam
Surabhi Gautam
BCBhavna Chawla
Bhavna Chawla
SKShiv Basant Kumar
Shiv Basant Kumar
SBShilpa Bisht
Shilpa Bisht
RDRima Dada
Rima Dada

30 May 2025 in Communications Biology
Verified
Journal Article
Open access
PDF file
SGSurabhi Gautam
Surabhi Gautam
JWJayla Elan Whittaker
Jayla Elan Whittaker
RVRushi Vekariya
Rushi Vekariya
Sergio Ramírez-PérezSergio Ramírez-Pérez
Sergio Ramírez-Pérez
UGUmesh Gangishetti
Umesh Gangishetti
BPBhattaram Pallavi
Bhattaram Pallavi
Patients suffering from rheumatoid arthritis (RA) and related autoimmune joint diseases exhibit cyclic episodes of resolution and exacerbation of joint inflammation, referred to as flares. Fibroblast-like synoviocytes (FLSs) that are epigenetically transformed by chronic inflammation are implicated as the orchestrators of these flares. In this study, we compared the cellular and molecular features of the FLSs during the inflammatory and resolution phases of RA progression. We performed histopathological evaluations of the joints from an inducible tumor necrosis factor-alpha (TNF-α) transgenic mouse model to reveal that phenotypic RA hallmarks including synovial hyperplasia, increased angiogenesis, and macrophage infiltration, were all reversed upon the initiation of resolution. However, the FLSs from the resolution phase joints exhibited a transcriptomic signature reminiscent of a highly inflammatory state. They exhibited a G0/G1 cell cycle arrest accompanied by reduced viability. In addition, factors secreted from the resolution FLSs, induced cell death, and decreased the angiogenic potential in human microvascular and umbilical cord endothelial cells. These findings indicate that the secretome of the resolution phase FLSs impairs endothelial cell function and suggest that understanding the interaction between the FLSs and endothelial cells during the resolution phase of RA is essential for achieving complete remission.